Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 nov. 2024 07h00 HE | Source: Sol-Gel Technologies Ltd.

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
20 mai 2024 07h00 HE | Source: Sol-Gel Technologies Ltd.

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
16 mai 2024 06h00 HE | Source: Sol-Gel Technologies Ltd.

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
01 avr. 2024 07h00 HE | Source: Sol-Gel Technologies Ltd.

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
13 mars 2024 07h00 HE | Source: Sol-Gel Technologies Ltd.

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments